Use of ustekinumab after other biological therapies in moderate-severe psoriasis: Real long-term data

Objective: Ustekinumab is used in moderate-severe plaque psoriasis with inadequate response to anti- tumour necrosis factor α drugs. Recent studies support the need to assess real long-term data. The aim of this study was to evaluate the real long-term effectiveness and safety of ustekinumab...

Full description

Bibliographic Details

Published in:	Farmacia Hospitalaria
Main Authors:	Manuel David Gil-Sierra, Esmeralda Ríos-Sánchez, María del Pilar Briceño-Casado
Format:	Article
Language:	English
Published:	Elsevier 2020-09-01
Subjects:	ustekinumab psoriasis retrospective studies treatment outcome drug evaluation studies
Online Access:	http://www.aulamedica.es/fh/pdf/11420.pdf